Company intelligence / Profile preview

Acuitive Technologies

Allendale, New Jersey, United States

Ownership: Private
Development stage: Other

Overview

Acuitive Technologies commercializes orthopedic implants and scaffolds using its proprietary CITREGEN synthetic biomaterial, which is designed to mimic nature's cellular support network and promote tissue regeneration. The company's products are used in repairing musculoskeletal injuries and bone defects, with successful market entry (FDA clearance or similar) for multiple devices.

Therapeutic areas: Other
Modalities: DeviceSynthetic biomaterial
Industry: Implantable Medical Devices

Beyond the preview

Go deeper on Acuitive Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Acuitive Technologies.

Explore the full profile